BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26437221)

  • 1. Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival.
    Fink SP; Myeroff LL; Kariv R; Platzer P; Xin B; Mikkola D; Lawrence E; Morris N; Nosrati A; Willson JK; Willis J; Veigl M; Barnholtz-Sloan JS; Wang Z; Markowitz SD
    Oncotarget; 2015 Oct; 6(31):30500-15. PubMed ID: 26437221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis in colorectal cancer.
    Zhang D; Zhao L; Shen Q; Lv Q; Jin M; Ma H; Nie X; Zheng X; Huang S; Zhou P; Wu G; Zhang T
    Int J Cancer; 2017 May; 140(10):2298-2309. PubMed ID: 28213952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIAA1199/CEMIP/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Koga A; Sato N; Kohi S; Yabuki K; Cheng XB; Hisaoka M; Hirata K
    Pancreatology; 2017; 17(1):115-122. PubMed ID: 28012880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
    Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
    J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia promotes colon cancer dissemination through up-regulation of cell migration-inducing protein (CEMIP).
    Evensen NA; Li Y; Kuscu C; Liu J; Cathcart J; Banach A; Zhang Q; Li E; Joshi S; Yang J; Denoya PI; Pastorekova S; Zucker S; Shroyer KR; Cao J
    Oncotarget; 2015 Aug; 6(24):20723-39. PubMed ID: 26009875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
    Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
    J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H3K27me3 loss plays a vital role in CEMIP mediated carcinogenesis and progression of breast cancer with poor prognosis.
    Hsieh IY; He J; Wang L; Lin B; Liang Z; Lu B; Chen W; Lu G; Li F; Lv W; Zhao W; Li J
    Biomed Pharmacother; 2020 Mar; 123():109728. PubMed ID: 31846842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of
    Ma WR; Xu P; Liu ZJ; Zhou J; Gu LK; Zhang J; Deng DJ
    World J Gastroenterol; 2020 Jan; 26(2):184-198. PubMed ID: 31988584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colon cancer secreted protein-2 (CCSP-2), a novel candidate serological marker of colon neoplasia.
    Xin B; Platzer P; Fink SP; Reese L; Nosrati A; Willson JK; Wilson K; Markowitz S
    Oncogene; 2005 Jan; 24(4):724-31. PubMed ID: 15580307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of CHAF1A, a poor prognostic factor, facilitates cell proliferation of colon cancer.
    Wu Z; Cui F; Yu F; Peng X; Jiang T; Chen D; Lu S; Tang H; Peng Z
    Biochem Biophys Res Commun; 2014 Jun; 449(2):208-15. PubMed ID: 24845563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal VCAN expression as a potential prognostic biomarker for disease recurrence in stage II-III colon cancer.
    Chida S; Okayama H; Noda M; Saito K; Nakajima T; Aoto K; Hayase S; Momma T; Ohki S; Kono K; Takenoshita S
    Carcinogenesis; 2016 Sep; 37(9):878-887. PubMed ID: 27287872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2.
    Zhang Y; Lin C; Liao G; Liu S; Ding J; Tang F; Wang Z; Liang X; Li B; Wei Y; Huang Q; Li X; Tang B
    Oncotarget; 2015 Oct; 6(32):32586-601. PubMed ID: 26452129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.
    Dalerba P; Sahoo D; Paik S; Guo X; Yothers G; Song N; Wilcox-Fogel N; Forgó E; Rajendran PS; Miranda SP; Hisamori S; Hutchison J; Kalisky T; Qian D; Wolmark N; Fisher GA; van de Rijn M; Clarke MF
    N Engl J Med; 2016 Jan; 374(3):211-22. PubMed ID: 26789870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LOXL2 Is Highly Expressed in Cancer-Associated Fibroblasts and Associates to Poor Colon Cancer Survival.
    Torres S; Garcia-Palmero I; Herrera M; Bartolomé RA; Peña C; Fernandez-Aceñero MJ; Padilla G; Peláez-García A; Lopez-Lucendo M; Rodriguez-Merlo R; García de Herreros A; Bonilla F; Casal JI
    Clin Cancer Res; 2015 Nov; 21(21):4892-902. PubMed ID: 26206869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of REST in breast cancer promotes tumor progression through estrogen sensitization, MMP24 and CEMIP overexpression.
    Cloud AS; Vargheese AM; Gunewardena S; Shimak RM; Ganeshkumar S; Kumaraswamy E; Jensen RA; Chennathukuzhi VM
    BMC Cancer; 2022 Feb; 22(1):180. PubMed ID: 35177031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice.
    Zhao J; Bulek K; Gulen MF; Zepp JA; Karagkounis G; Martin BN; Zhou H; Yu M; Liu X; Huang E; Fox PL; Kalady MF; Markowitz SD; Li X
    Gastroenterology; 2015 Dec; 149(7):1860-1871.e8. PubMed ID: 26344057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of the adenoma-carcinoma progression and Cdc25A-B phosphatases by the trefoil factor TFF1 in human colon epithelial cells.
    Rodrigues S; Rodrigue CM; Attoub S; Fléjou JF; Bruyneel E; Bracke M; Emami S; Gespach C
    Oncogene; 2006 Oct; 25(50):6628-36. PubMed ID: 16715141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined use of CEMIP and CA 19-9 enhances diagnostic accuracy for pancreatic cancer.
    Lee HS; Jang CY; Kim SA; Park SB; Jung DE; Kim BO; Kim HY; Chung MJ; Park JY; Bang S; Park SW; Song SY
    Sci Rep; 2018 Feb; 8(1):3383. PubMed ID: 29467409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of eIF3e is correlated with colon tumor development and poor prognosis.
    Li Z; Lin S; Jiang T; Wang J; Lu H; Tang H; Teng M; Fan J
    Int J Clin Exp Pathol; 2014; 7(10):6462-74. PubMed ID: 25400724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer.
    Rashad Y; Olsson L; Israelsson A; Öberg Å; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Tumour Biol; 2018 Sep; 40(9):1010428318799251. PubMed ID: 30198422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.